Pasithea Therapeutics Corp. - Common Stock, $0.0001 par value per share (KTTA)

Historical Holders from Q1 2024 to Q3 2025

Symbol
KTTA on Nasdaq
CUSIP
70261F202
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
8.34M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
612K
Holdings value
$441K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
18
Number of buys
12
Number of sells
-5
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pasithea Therapeutics Corp. - Common Stock, $0.0001 par value per share (KTTA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVI Investments, Inc. 9.9% 0% $702K $169K 826K +31.7% CVI Investments, Inc. Jun 30, 2025
Orca Capital AG 4.9% -13.3% $515K -$11.8K 363K -2.23% Orca Capital AG May 7, 2025
INTRACOASTAL CAPITAL, LLC 4.99% $451K 318K Mitchell P. Kopin May 6, 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $202K $11.8K 142K +6.2% Armistice Capital, LLC Mar 31, 2025
STEINMAN LAWRENCE 3.1% $119K 83.9K Lawrence Steinman Mar 1, 2025

Institutional Holders of Pasithea Therapeutics Corp. - Common Stock, $0.0001 par value per share (KTTA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 612K $441K +$225K $0.73 18
2025 Q2 300K $217K +$152K $0.72 10
2025 Q1 78.7K $99.1K -$117K $1.30 7
2024 Q4 77.2K $243K +$214K $3.15 7
2024 Q3 9.09K $48.9K -$103K $5.42 6
2024 Q2 30K $152K -$300 $5.06 7
2024 Q1 30.1K $218K +$218K $7.28 6